Clinical Trial Update: Study to Investigate the Safety and Activity of Aldoxorubicin Plus Ifosfamide/Mesna in Subjects With Metastatic Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 trial evaluating aldoxorubicin in combination with ifosfamide/Mesna for metastatic, unresectable soft tissue sarcoma; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Aldoxorubicin (aldoxorubicin)
• IFOSFAMIDE (IFOSFAMIDE)
• MESNA (MESNA)

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-29